Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Onco-Innovations Ltd. (TSE:ONCO)
:ONCO
ONCO Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.56 - C$2.65
Previous CloseN/A
Volume353.06K
Average Volume (3M)471.58K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)18.52K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta5.85
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding43,375,000
10 Day Avg. Volume1,013,784
30 Day Avg. Volume471,579
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-106.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Onco-Innovations Ltd. News
PremiumCompany Announcements
Onco-Innovations Applauds Landmark Donation and Extends Marketing Engagement
PremiumCompany Announcements
Onco-Innovations Acquires Inka Health to Boost AI-Driven Cancer Research
PremiumCompany Announcements
Onco-Innovations Unveils Promising PNKP Inhibitors to Boost Chemotherapy
---
Options Prices
Currently, No data available
---
Ownership Overview
0.11%
Insiders
―
Mutual Funds
― Other Institutional Investors
99.89% Public Companies and
Individual Investors
ONCO FAQ
What was Onco-Innovations Ltd.’s price range in the past 12 months?
Onco-Innovations Ltd. lowest stock price was C$0.56 and its highest was C$2.65 in the past 12 months.
What is Onco-Innovations Ltd.’s market cap?
Currently, no data Available
When is Onco-Innovations Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Onco-Innovations Ltd.’s earnings last quarter?
Currently, no data Available
Is Onco-Innovations Ltd. overvalued?
According to Wall Street analysts Onco-Innovations Ltd.’s price is currently Overvalued.
Does Onco-Innovations Ltd. pay dividends?
Onco-Innovations Ltd. does not currently pay dividends.
What is Onco-Innovations Ltd.’s EPS estimate?
Onco-Innovations Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Onco-Innovations Ltd. have?
Onco-Innovations Ltd. has 43,375,000 shares outstanding.
What happened to Onco-Innovations Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Onco-Innovations Ltd.?
Currently, no hedge funds are holding shares in TSE:ONCO
---
Company Description
Onco-Innovations Ltd.
Onco-Innovations Limited is a Canadian biotech company dedicated to developing and commercializing treatments for various types of cancer. The company holds an exclusive license for the PNKP Inhibitor Technology and an exclusive sublicense for the Drug Delivery Technology. Together, these technologies have shown the potential to significantly enhance treatment outcomes, particularly for colorectal cancer.
---
Technical Analysis
---